Report on FDA Infant Formula Response May Spur Reforms for Inspections, Recalls, Complaint Handling

Dennis Tosh
June 26, 2024 at 04:36 PM EST
Image Image
A Department of Health and Human Services (HHS) Office of Inspector General (OIG) report criticizing the FDA’s inspection and recall processes in the wake of the discovery of quality problems with Abbott Laboratories infant formula products may lead to reforms that improve the FDA’s ability to respond to whistleblower complaints and to conduct timely mission-critical inspectio... Read More